Literature DB >> 18974697

Inflammation in venous disease.

P Zamboni1, S Lanzara, F Mascoli, A Caggiati, A Liboni.   

Abstract

Chronic venous disease (CVD), mainly due to venous reflux or, sometimes, to venous outflow obstruction, produces a microcirculatory overload leading to the impairment of venous drainage. Venous drainage depends primarily on a major hemodynamic parameter called trans-mural pressure (TMP). TMP is increased in patients affected by CVD, leading to impaired tissue drainage, and, consequently, facilitating the beginning of the inflammatory cascade. Increased TMP determines red blood cell extravasation and either dermal hemosiderin deposits or iron laden-phagocytes. Iron deposits are readily visible in the legs of all patients affected by severe CVD. Local iron overload could generate free radicals or activate a proteolytic hyperactivity of metalloproteinases (MMPs) and/or downregulate tissue inhibitors of MMPs. These negative effects are particularly evident in carriers of the common HFE gene's mutations C282Y and H63D, because intracellular iron deposits of mutated macrophages have less stability than those of the wild type, inducing a significant oxidative stress. It has been demonstrated that such genetic variants increase the risk of ulcers and advance the age of ulcer onset, respectively. The iron-dependent vision of inflammation in CVD paves the way to new therapeutic strategies including the deliberate induction of iron deficiency as a treatment modality for non-healing and/or recurrent venous leg ulcers. The inflammatory cascade in CVD shares several aspects with that activated in the course of multiple sclerosis, an inflammatory and neurodegenerative disease of unknown origin in which the impairment of cerebral venous outflow mechanisms has been recently demonstrated.

Entities:  

Mesh:

Year:  2008        PMID: 18974697

Source DB:  PubMed          Journal:  Int Angiol        ISSN: 0392-9590            Impact factor:   2.789


  5 in total

Review 1.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

2.  Chronic cerebrospinal venous insufficiency as a cause of multiple sclerosis: controversy and reality.

Authors:  Claudiu I Diaconu; Devon Conway; Robert J Fox; Alexander Rae-Grant
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-04

3.  Bleeding events are associated with an increase in markers of inflammation in acute coronary syndromes: an ACUITY trial substudy.

Authors:  Charles L Campbell; Steven R Steinhubl; William C Hooper; Joseph Jozic; Susan S Smyth; Debra Bernstein; Christine De Staercke; George Syros; Brian H Negus; Thomas Stuckey; Gregg W Stone; Roxana Mehran; George Dangas
Journal:  J Thromb Thrombolysis       Date:  2011-02       Impact factor: 2.300

4.  Mystery of chronic cerebrospinal venous insufficiency: identical venographic and ultrasound findings in patients with MS and controls.

Authors:  W McAuliffe; A G Kermode
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-31       Impact factor: 3.825

5.  Alterations in the Plasma and Red Blood Cell Properties in Patients with Varicose Vein: A Pilot Study.

Authors:  Lukasz Gwozdzinski; Anna Pieniazek; Joanna Bernasinska-Slomczewska; Pawel Hikisz; Krzysztof Gwozdzinski
Journal:  Cardiol Res Pract       Date:  2021-06-30       Impact factor: 1.866

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.